Literature DB >> 11003224

A study of the incidence and significance of intramammary enterobacterial infections acquired during the dry period.

A J Bradley1, M J Green.   

Abstract

We assessed the incidence of enterobacterial infection of the mammary glands of 629 cows, from six commercial herds in Somerset, during the nonlactating period; samples were collected from all clinical quarters of these cows during the subsequent lactation. A rise in the incidence of intramammary enterobacterial infection was detected between drying off and before calving. Quarters infected with an enterobacterial organism during the dry period were more likely to develop mastitis due to that pathogen than were uninfected quarters. Of all enterobacterial mastitis occurring in the first 100 d of lactation, 52.6% arose in quarters previously infected, during the dry period, with the same strain of bacteria, as identified by DNA fingerprinting using enterobacterial repetitive intergenic consensus primers. When compared with unsampled controls, quarters sampled during the dry period did not show a higher incidence of infection at calving or of subsequent clinical mastitis. These findings suggest that chronic infections are important in the epidemiology of enterobacterial mastitis and that environmental management during the dry period may greatly impact the incidence of enterobacterial mastitis in the subsequent lactation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003224     DOI: 10.3168/jds.S0022-0302(00)75072-7

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  16 in total

1.  Adaptation of Escherichia coli to the bovine mammary gland.

Authors:  A J Bradley; M J Green
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Making Good Decisions on Dry Cow Management to Improve Udder Health - Synthesising Evidence in a Bayesian Framework.

Authors:  Martin Green; Jon Huxley; Aurelien Madouasse; William Browne; Graham Medley; Andrew Bradley; Andrew Biggs; James Breen; Mark Burnell; Alistair Hayton; James Husband; Jon Reader; Jon Statham; Mike Thorne
Journal:  Cattle Pract       Date:  2008       Impact factor: 0.071

3.  Quarter and cow risk factors associated with the occurrence of clinical mastitis in dairy cows in the United Kingdom.

Authors:  J E Breen; M J Green; A J Bradley
Journal:  J Dairy Sci       Date:  2009-06       Impact factor: 4.034

4.  Cow, farm, and management factors during the dry period that determine the rate of clinical mastitis after calving.

Authors:  M J Green; A J Bradley; G F Medley; W J Browne
Journal:  J Dairy Sci       Date:  2007-08       Impact factor: 4.034

Review 5.  Molecular epidemiology of mastitis pathogens of dairy cattle and comparative relevance to humans.

Authors:  Ruth N Zadoks; John R Middleton; Scott McDougall; Jorgen Katholm; Ynte H Schukken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

6.  Changing trends in mastitis.

Authors:  Rn Zadoks; Jl Fitzpatrick
Journal:  Ir Vet J       Date:  2009-04-01       Impact factor: 2.146

7.  Current management practices and interventions prioritised as part of a nationwide mastitis control plan.

Authors:  P M Down; A J Bradley; J E Breen; C D Hudson; M J Green
Journal:  Vet Rec       Date:  2016-03-10       Impact factor: 2.695

8.  A Bayesian micro-simulation to evaluate the cost-effectiveness of interventions for mastitis control during the dry period in UK dairy herds.

Authors:  P M Down; A J Bradley; J E Breen; W J Browne; T Kypraios; M J Green
Journal:  Prev Vet Med       Date:  2016-09-14       Impact factor: 2.670

9.  A Case Study of Behaviour and Performance of Confined or Pastured Cows During the Dry Period.

Authors:  Randi A Black; Peter D Krawczel
Journal:  Animals (Basel)       Date:  2016-07-13       Impact factor: 2.752

10.  A cross-sectional study of 329 farms in England to identify risk factors for ovine clinical mastitis.

Authors:  S Cooper; S J Huntley; R Crump; F Lovatt; L E Green
Journal:  Prev Vet Med       Date:  2016-01-14       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.